The Amtech Esters IPO is a closed SME Bookbuilding offer (Fresh capital only) that opened on 9 September 2026. The Amtech Esters IPO closed on 11 September 2026, with an issue price of ₹75 per share. The Amtech Esters IPO has a face value of ₹10 and a lot size of 1,600 shares. The Amtech Esters IPO is listed on 17 September 2026. The Amtech Esters IPO allotment was scheduled for 15 September 2026.
On the financial front, the Amtech Esters IPO reported revenue of ₹26 crore for 30 Nov 2025, compared with ₹37 crore for 31 Mar 2025. The Amtech Esters IPO PAT was ₹2 crore against ₹4 crore. The Amtech Esters IPO EBITDA stood at ₹5 crore with a 18.41% margin. The Amtech Esters IPO net worth as of 30 Nov 2025 was ₹18 crore.
Always verify The Amtech Esters IPO details and GMP data with the official offer document before investing in the Amtech Esters IPO.
Financial Summary
Amount in ₹ Crores
Metric
30 Nov 2025
31 Mar 2025
31 Mar 2024
Total Assets
34
28
25
Revenue
26
37
27
PAT
2
4
3
EBITDA
5
7
2
Net Worth
18
15
12
Reserves
15
12
8
Total Borrowing
4
4
4
Amtech Esters IPO Financials FAQs
Revenue of Amtech Esters (Amount in ₹ Crores) — 30 Nov 2025: 26; 31 Mar 2025: 37; 31 Mar 2024: 27. Profit after tax (PAT) — 30 Nov 2025: 2; 31 Mar 2025: 4; 31 Mar 2024: 3.
EBITDA of Amtech Esters (Amount in ₹ Crores) — 30 Nov 2025: 5; 31 Mar 2025: 7; 31 Mar 2024: 2. The EBITDA margin is 18.41%.
Total assets — 30 Nov 2025: 34; 31 Mar 2025: 28; 31 Mar 2024: 25. Net worth — 30 Nov 2025: 18; 31 Mar 2025: 15; 31 Mar 2024: 12. Reserves & surplus — 30 Nov 2025: 15; 31 Mar 2025: 12; 31 Mar 2024: 8. (Amount in ₹ Crores)
Total borrowing of Amtech Esters (Amount in ₹ Crores) — 30 Nov 2025: 4; 31 Mar 2025: 4; 31 Mar 2024: 4. Debt-to-equity ratio: 0.17.
The financials shown for Amtech Esters IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
